Healthcare -
Biotechnology - NASDAQ - US
$ 9.235
-2.69 %
$ 2.84 B
Market Cap
-51.31
P/E
FOLD - OPERATING INCOME
Operating Income FOLD - Amicus Therapeutics, Inc.
24.9 M
LAST VALUE
45.66%
2 YEAR CAGR
15.80%
5 YEAR CAGR
8.98%
10 YEAR CAGR